Novartis reputation fails to block rival drugmaker's 'Devatis' EU trademarks
By Inbar Preiss ( September 23, 2026, 13:35 GMT | Insight) -- EU judges have set limits on how far a well-known drugmaker's brand can reach, as Swiss pharmaceutical giant Novartis lost its challenge against a Turkish competitor over “Devatis” trademarks.Swiss pharmaceutical giant Novartis’s strong reputation cannot prevent rivals from registering trademarks with similarities to its name, the EU's lower-tier court ruled Wednesday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.